Prof. Dr. Steffi Lehmann
Prof. Dr. Steffi Lehmann
ZHAW
School of Life Sciences and Facility Management
Section for Pharmaceutical Technology and Pharmacology
Einsiedlerstrasse 31
8820 Wädenswil
Work at ZHAW
Position
- Head of Pharmaceutical Technology / Pharmacology Group
- Head of MSc Specialization in Pharmaceutical Biotechnology
Projects
- SpectralPad / Project co-leader / Project ongoing
- Novel phage derived antimicrobials / Project leader / Project ongoing
- Aroma beladene mesoporöse Silicapartikel (MSP) für Dropz / Project leader / Project ongoing
- Active modified surfaces for contained drug release / Project leader / Project completed
- Extracellular vesicles for targeted delivery of new antimicrobials / Project leader / Project completed
- Infused Drinking Water from Dropz / Deputy project leader / Project completed
- Development of novel tablet formulations for the detection of pathogenic bacteria / Project leader / Project completed
- Molekulare Analyse von CD30+ Lymphoma / Project leader / Project completed
- Modulatoren der MMP-Hemopexin-Domäne / Project co-leader / Project completed
- Preventing capsular contracture by coating of silicone implants with bioglass / Project leader / Project completed
Publications
-
Sabani, Besmira; Brand, Michael; Albert, Ina; Inderbitzin, Joelle; Eichenseher, Fritz; Schmelcher, Mathias; Rohrer, Jack; Riedl, Rainer; Lehmann, Steffi,
2023.
Nanomedicine: Nanotechnology, Biology and Medicine.
47(102607).
Available from: https://doi.org/10.1016/j.nano.2022.102607
Other publications
Sabani B, Brand M, Albert I, Inderbitzin J, Eichenseher F, Schmelcher M, Rohrer J, Riedl R, Lehmann S. A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging. Nanomedicine. 2023 Jan;47:102607. doi: 10.1016/j.nano.2022.102607. Epub 2022 Sep 24. PMID: 36167305.